(Total Views: 98)
Posted On: 10/09/2018 8:41:11 AM
Post# of 44826

$RGBP Regen BioPharma, Inc. Determines Its Lead NR2F6 Agonist Ready for Inflammatory Bowel Disease Animal Studies
https://finance.yahoo.com/news/regen-biopharm...00491.html
https://finance.yahoo.com/news/regen-biopharm...00491.html

